» Articles » PMID: 35563879

Nano-Sized Extracellular Vesicles Secreted from GATA-4 Modified Mesenchymal Stem Cells Promote Angiogenesis by Delivering Let-7 MiRNAs

Overview
Journal Cells
Publisher MDPI
Date 2022 May 14
PMID 35563879
Authors
Affiliations
Soon will be listed here.
Abstract

We demonstrated previously that extracellular vesicles (EVs) released from mesenchymal stem cells (MSCs) play a critical role in angiogenesis. Here, we examine whether this pro-angiogenic efficacy is enhanced in EVs derived from MSCs overexpressing GATA-4 (MSC). Methods and Results. EVs were isolated from MSC (EV) and control MSCs transduced with an empty vector (EV). EVs from both cell types were of the same size and displayed similar molecular markers. Compared with EV, EV increased both a tube-like structure formation and spheroid-based sprouting of human umbilical vein endothelial cells (HUVECs). The EV increased the numbers of CD31-positive cells and hemoglobin content inside Matrigel plugs subcutaneously transplanted into mice for 2 weeks. Moreover, EV encapsulated higher levels of let-7 family miRs compared to EV. The transfer of exosomal let-7 miRs into HUVECs was recorded with an accompanied down-regulation of thrombospondin-1 (THBS1) expression, a major endogenous angiogenesis inhibitor. The loss-and-gain of function studies of let-7 miRs showed that let-7f knockdown significantly decreased EV-mediated vascularization inside Matrigel plugs. In contrast, let-7f overexpression promoted HUVEC migration and tube formation. Conclusion. Our results indicate that EVs derived from genetically modified MSCs with GATA-4 overexpression had increased pro-angiogenic capacity due to the delivery of let-7 miRs that targeted THBS1 in endothelial cells.

Citing Articles

Recent Insights into Endogenous Mammalian Cardiac Regeneration Post-Myocardial Infarction.

Fiorino E, Rossin D, Vanni R, Aubry M, Giachino C, Rastaldo R Int J Mol Sci. 2024; 25(21).

PMID: 39519298 PMC: 11546116. DOI: 10.3390/ijms252111747.


Lin28 affects the proliferation and osteogenic differentiation of human dental pulp stem cells by directly inhibiting let-7b maturation.

Yan L, Sun J, Wang Y, Liu X, Hu J, Sun M BDJ Open. 2024; 10(1):17.

PMID: 38443392 PMC: 10914815. DOI: 10.1038/s41405-024-00194-8.


The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS.

Santos C, Lopes-Pacheco M, English K, Rolandsson Enes S, Krasnodembskaya A, Rocco P Cells. 2024; 13(2).

PMID: 38247814 PMC: 10813908. DOI: 10.3390/cells13020122.


Mesenchymal Stem Cell-Derived Extracellular Vesicles: An Emerging Diagnostic and Therapeutic Biomolecules for Neurodegenerative Disabilities.

Kandeel M, Morsy M, Alkhodair K, Alhojaily S Biomolecules. 2023; 13(8).

PMID: 37627315 PMC: 10452295. DOI: 10.3390/biom13081250.


Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases.

Yuan Y, Wang J, Zhang Y, Li L, Reza A, Gurunathan S Int J Nanomedicine. 2023; 18:3177-3210.

PMID: 37337578 PMC: 10276992. DOI: 10.2147/IJN.S407029.


References
1.
Shafei A, Ali M, Ghanem H, Shehata A, Abdelgawad A, Handal H . Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction. J Cell Biochem. 2017; 119(7):5274-5286. DOI: 10.1002/jcb.26637. View

2.
Rysa J, Tenhunen O, Serpi R, Soini Y, Nemer M, Leskinen H . GATA-4 is an angiogenic survival factor of the infarcted heart. Circ Heart Fail. 2010; 3(3):440-50. DOI: 10.1161/CIRCHEARTFAILURE.109.889642. View

3.
Sahoo S, Losordo D . Exosomes and cardiac repair after myocardial infarction. Circ Res. 2014; 114(2):333-44. DOI: 10.1161/CIRCRESAHA.114.300639. View

4.
Abreu S, Weiss D, Rocco P . Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?. Stem Cell Res Ther. 2016; 7(1):53. PMC: 4831172. DOI: 10.1186/s13287-016-0317-0. View

5.
Kinnaird T, Stabile E, Burnett M, Lee C, Barr S, Fuchs S . Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004; 94(5):678-85. DOI: 10.1161/01.RES.0000118601.37875.AC. View